NEW YORK, NY (February 7, 2017) — Dr. David Carr-Locke has been recruited as clinical director of the Center for Advanced Digestive Care (CADC) at NewYork-Presbyterian/Weill Cornell Medical Center, where he will be reporting to the Executive Directors. He has also been recruited as a professor of medicine at Weill Cornell Medicine. Dr. Carr-Locke joins the institutions from Mount Sinai Beth Israel Medical Center, New York where he was chief of the Division of Digestive Diseases and associate chair of the Department of Medicine. He was formerly director of endoscopy at Brigham and Women’s Hospital, Boston.
For more than 40 years, Dr. Carr-Locke has been a national and international leader in the field of therapeutic endoscopy. His research focuses on the role of gastrointestinal endoscopy in the diagnosis and treatment of gastrointestinal, pancreatic and biliary disease. Working with physician and industry partners, he creates and improves endoscopic devices and accessories to provide minimally invasive and micro-invasive treatment methods.
In his new role, Dr. Carr-Locke oversees the development and implementation of the CADC’s services, which range from screening colonoscopies in healthy patients to complex endoscopic procedures and surgery. The CADC’s future location will be in the new David H. Koch Center, set to open on York Avenue between 68th and 69th Streets in 2018. His focus is to make procedures less invasive compared with the open surgery of the past, and bring together all of the disciplines that treat GI diseases – endoscopy, gastrointestinal and hepatobiliary surgery, nutrition, pathology and radiology – into one centralized location.
“Dr. Carr-Locke is an esteemed physician and expert whose commitment to treating gastrointestinal diseases has been instrumental in providing minimally invasive options for disease management,” said Dr. David E. Cohen, chief of gastroenterology and hepatology at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine. “We are very excited to welcome him to NewYork-Presbyterian and Weill Cornell Medicine. He will play a vital part in advancing the CADC’s mission to provide world-class digestive care.”
“I am delighted to be joining two world-renowned institutions committed to providing the best possible care for patients,” Dr. Carr-Locke said. “My mission is to change the way digestive diseases are treated, with an emphasis on greater convenience and broader expertise for patients.”
The CADC’s multidisciplinary approach allows patients to walk in, access innovative treatment and go home, often on the same day due to the center’s emphasis on minimally invasive procedures. By having GI physicians and researchers all under the same roof, the CADC is working to create therapies that will treat a wider group of patients with tailored treatments, fewer risks, shorter hospital stays and lower costs.
“Innovation is the cornerstone of the CADC,” Dr. Carr-Locke said. “We hope to expand the existing possibilities of endoscopic intervention to treat benign and malignant GI tumors, disorders of the bile duct, gallbladder and pancreas, manage metabolic disorders like diabetes and obesity, and diagnose and treat more disorders of GI tract motility where muscular coordination of the GI tract has become abnormal.”
Dr. Carr-Locke received his medical degree from Cambridge University in England. He completed residencies at Kettering General Hospital and Leicester Hospitals and his senior residency at the University of Leicester, all in the U.K., with a clinical research fellowship at New England Baptist Hospital in Boston. He is a past-president of the International Hepato Pancreato Biliary Association and the American Society for Gastrointestinal Endoscopy. He is currently on the Governing Council of the New York Society for Gastrointestinal Endoscopy.
He has authored or co-authored more than 300 published papers, articles and book chapters, many of which have influenced teaching in endoscopy.
Dr. Carr-Locke has been listed in New York Magazine's "Best Doctors" annual list since 2010 and on Castle Connelly’s America’s Top Doctors since 2000.
NewYork-Presbyterian is one of the nation’s most comprehensive healthcare delivery networks, focused on providing innovative and compassionate care to patients in the New York metropolitan area and around the globe. In collaboration with two renowned medical school partners, Weill Cornell Medicine and Columbia University College of Physicians & Surgeons, NewYork-Presbyterian is consistently recognized as a leader in medical education, groundbreaking research and clinical innovation.
NewYork-Presbyterian has four major divisions: NewYork-Presbyterian Hospital is ranked #1 in the New York metropolitan area by U.S. News and World Report and repeatedly named to the magazine’s Honor Roll of best hospitals in the nation; NewYork-Presbyterian Regional Hospital Network is comprised of leading hospitals in and around New York and delivers high-quality care to patients throughout the region; NewYork-Presbyterian Physician Services connects medical experts with patients in their communities; and NewYork-Presbyterian Community and Population Health features the hospital’s ambulatory care network sites and operations, community care initiatives and healthcare quality programs, including NewYork Quality Care, established by NewYork-Presbyterian, Weill Cornell and Columbia.
NewYork-Presbyterian is one of the largest healthcare providers in the U.S. Each year, nearly 29,000 NewYork-Presbyterian professionals deliver exceptional care to more than 2 million patients.
For more information, visit www.nyp.org and find us on Facebook, Twitter and YouTube.
Weill Cornell Medicine
Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world. The doctors and scientists of Weill Cornell Medicine—faculty from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, and Weill Cornell Physician Organization—are engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Located in the heart of the Upper East Side’s scientific corridor, Weill Cornell Medicine’s powerful network of collaborators extends to its parent university Cornell University; to Qatar, where an international campus offers a U.S. medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medicine faculty provide comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, NewYork-Presbyterian Lower Manhattan Hospital and NewYork-Presbyterian Queens. Weill Cornell Medicine is also affiliated with Houston Methodist. For more information, visit weill.cornell.edu.